Archives: Agenda

• Technology and new developments when it comes to managing CRO relationships
• How to ensure your study is prioritized
• Maintaining a strong relationship with vendors in remote and hybrid work settings
• How to blend a CRO team with your internal team in order to foster communication and overall success of your trial
• CRO monitoring and oversight: how to make processes efficient and effective

• Ensuring your trial is cost-conscious and efficient without compromising on quality or on patient care
• Forecasting and budgeting in order to accurately predict costs and minimize unforeseen expenses
• Keeping your clinical budget on track
• Negotiating prices and contracts in order to ensure maximum benefit without going over budget

MODERATOR
Rene Stephens, Managing Director, Clinical Business Operations, Danforth Advisors

• Understanding Gen AI — Why it matters for clinical operations
• Trends & Barriers — What’s driving adoption or impeding progress
• GenAI in Action — Real world use cases that are transforming clinical ops

• Analyzing current market dynamics and funding trends shaping biotech growth in 2025
• Addressing ongoing talent shortages and evolving workforce strategies
• Funding and investment for biotechs in and around Boston: how has this shifted in 2025?
• The impact of national political and economic changes on the biotech landscape in Boston and New England

MODERATOR: Gregg Beloff, Founder, Danforth Health

• Discover the benefits this model brings to strategic asset development
• Understand the optimal timepoints for CRO engagement
• Discuss tips for maximizing your CRO’s expertise to support a comprehensive development plan
• Review real-world examples demonstrating the advantages of this approach

• 10 months in: how has the new administration affected the pharma and biotech industry in New England?
• Dealing with change and uncertainty: ensuring your clinical trial timelines stay on track
• Discussing pros and cons of running trials in the US vs overseas considering recent changes
• How have funding and resources been affected in 2025 and how has this impacted outsourcing and clinical operations?

MODERATOR Revati Tatake, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical operations. Roundtables will take place in the Stream A conference room.